MEI

MEI Pharma Reports Third Quarter Fiscal Year 2024 Results and Operational Highlights

Retrieved on: 
木曜日, 5月 9, 2024
Biotechnology, Pharmaceutical, Health, Oncology, CDK9, Investment, Venetoclax, Research, MEI, Trial of the century, Bevacizumab, AML, Cohort, Oxidative phosphorylation, Wind, Disease, Week, IDH, Patient, Toxicity, Acute myeloid leukemia, FLT3, Clinical trial, Calendar, Pharmaceutical industry

“Over the past several months, MEI has received encouraging clinical data for voruciclib and ME-344 supporting the further development of these programs,” said David Urso, president and chief executive officer of MEI Pharma.

Key Points: 
  • “Over the past several months, MEI has received encouraging clinical data for voruciclib and ME-344 supporting the further development of these programs,” said David Urso, president and chief executive officer of MEI Pharma.
  • As of March 31, 2024, MEI had $56.6 million in cash, cash equivalents, and short-term investments with no outstanding debt.
  • Research and development expenses decreased by $9.9 million to $5.2 million for the quarter ended March 31, 2024, compared to $15.1 million for the quarter ended March 31, 2023.
  • MEI recognized no revenue for the quarter ended March 31, 2024, compared to $5.9 million for the quarter ended March 31, 2023.

Pharmacist-led clinics improve access to health care: Lessons from Alberta

Retrieved on: 
木曜日, 5月 9, 2024
Pharmacist, Hospital, Publication, MEI, Entrepreneurship, Public policy, Pressure, Patient, Montreal Economic Institute, Nursing

“Pharmacists know medication better than anyone else in our health systems,” explains Krystle Wittevrongel, senior public policy analyst and Alberta project lead at the MEI.

Key Points: 
  • “Pharmacists know medication better than anyone else in our health systems,” explains Krystle Wittevrongel, senior public policy analyst and Alberta project lead at the MEI.
  • It is expected that there will be 103 such clinics active in the province by the end of 2024.
  • The researcher also links the success of the pharmacist-led clinic model in Alberta to pharmacists' expanded scope of practice in the province.
  • “By enabling pharmacists to play a larger role in its health system, Alberta is redirecting minor cases from emergency rooms to more appropriate facilities,” said Wittevrongel.

Alberta should fund hospitals based on treatments performed to ease chronic wait times, urges MEI

Retrieved on: 
木曜日, 4月 25, 2024
Magnetic resonance imaging, Hospital, Publication, MEI, Entrepreneurship, Public policy, Radiology, Patient, Montreal Economic Institute, Colonoscopy, MRI, Health insurance

MONTREAL, April 25, 2024 (GLOBE NEWSWIRE) -- Adopting activity-based funding for hospitals in Alberta could shorten wait times and improve productivity, according to a Montreal Economic Institute study.

Key Points: 
  • MONTREAL, April 25, 2024 (GLOBE NEWSWIRE) -- Adopting activity-based funding for hospitals in Alberta could shorten wait times and improve productivity, according to a Montreal Economic Institute study.
  • Quebec is transitioning to a model known as “activity-based funding.” Under this system, hospitals receive a fixed payment for each treatment delivered.
  • In the radiology and oncology sector, productivity increased by 26 per cent while procedure costs decreased by seven per cent.
  • Through its publications, media appearances, and advisory services to policy-makers, the MEI stimulates public policy debate and reforms based on sound economics and entrepreneurship.

MEI-Ipsos poll: Half of Canadians are dissatisfied with their provincial health care systems

Retrieved on: 
木曜日, 4月 11, 2024
Ageing, Public policy, Medicare, Private sector, Québécois people, Publication, MEI, Entrepreneurship, Legault, Growth, Health insurance

MONTREAL, April 11, 2024 (GLOBE NEWSWIRE) -- Dissatisfied with the state of their provincial health care systems, a majority of Canadians are open to greater reliance on the private sector, according to an MEI-Ipsos poll published this morning.

Key Points: 
  • MONTREAL, April 11, 2024 (GLOBE NEWSWIRE) -- Dissatisfied with the state of their provincial health care systems, a majority of Canadians are open to greater reliance on the private sector, according to an MEI-Ipsos poll published this morning.
  • “People understand that the endless waiting lists that characterize our government-run health systems will not be solved by yet another bureaucratic reform,” explains Emmanuelle B. Faubert, economist at the MEI.
  • “They can see that elsewhere in the world, mixed systems that allow more room for independent care providers don’t have the wait times that we have.”
    The results of the poll show that 50 per cent of Canadians are dissatisfied with their provincial health care systems.
  • The poll also shows that 52 per cent of Canadians agree with the idea of allowing greater access to private health care, while 29 per cent are opposed.

MEI Pharma Board of Directors Aligns on Strategy to Advance Voruciclib and ME-344

Retrieved on: 
木曜日, 4月 11, 2024
Biotechnology, Health, Pharmaceutical, Clinical Trials, Oncology, Agreement, Patient, Cancer, Mutation, CDK9, Venetoclax, Colorectal cancer, MEI, Bevacizumab, AML, Research, Cohort, Salvage therapy, Disease, Exercise, Therapy, IDH, Incidence, Neoplasm, Toxicity, Acute myeloid leukemia, FLT3, Standard of care, Death, Clinical trial, VEGF, Calendar, Pharmaceutical industry

With the MEI Board aligned around our strategy, we have a productive framework to advance both clinical programs in a manner intended to address significant medical needs while prioritizing a measured and objective-based allocation of our resources,” said David Urso, president and chief executive officer of MEI Pharma.

Key Points: 
  • With the MEI Board aligned around our strategy, we have a productive framework to advance both clinical programs in a manner intended to address significant medical needs while prioritizing a measured and objective-based allocation of our resources,” said David Urso, president and chief executive officer of MEI Pharma.
  • The plan builds on encouraging recently reported voruciclib clinical data and ME-344 data separately reported today.
  • Under the plan, the ongoing voruciclib development strategy will be guided by future clinical trial results and applicable regulatory authority advice.
  • The goal of the formulation effort is to increase biological activity, improve patient convenience of administration and increase commercial opportunity.

JBG SMITH Releases Statement on Potomac Yard Entertainment District Proposal

Retrieved on: 
水曜日, 3月 27, 2024
Commercial Building & Real Estate, Construction & Property, General Sports, Sports, Entertainment, Urban Planning, Other Entertainment, General Entertainment, Other Construction & Property, JBG, Growth, The Washington Post, Municipal council, Trust, Senate, SMITH, City, Economic development, Washington Capitals, Politics, Transport, Commonwealth, Monumental, Housing, Investment, Tysons, Virginia, Washington Wizards, Virginia Senate, MEI, Metro

JBG SMITH (NYSE: JBGS) today issued a statement on the Potomac Yard Entertainment District.

Key Points: 
  • JBG SMITH (NYSE: JBGS) today issued a statement on the Potomac Yard Entertainment District.
  • In December, we announced plans to develop an entertainment district in Potomac Yard, anchored by the Washington Capitals, Washington Wizards and the Monumental Sports & Entertainment corporate headquarters.
  • Today it was announced that discussions between Monumental, Alexandria and the Commonwealth of Virginia have been terminated.
  • This was a once-in-a-generation opportunity to build a world-class arena and entertainment district at Potomac Yard and to realize the vision of that community as a dense, mixed-use neighborhood.

NTT to Host Upgrade 2024 Global Research & Innovation Summit

Retrieved on: 
月曜日, 3月 11, 2024
Technology, Security, Other Technology, Health Technology, Software, Networks, Internet, Health, Data Management, IOT (Internet of Things), Pixar, Wireless network, PHI, Information, POC, LLM, The Walt Disney Company, Reality, Photosynthesis, Research, Microsoft, Instrument, MEI, Lucasfilm, CO2, Master of ceremonies, Privacy, Metreon, Physics, Climate change, Luhn algorithm, Intelligence, Nippon Telegraph and Telephone, NTT Data, AI, Student, TFLN, Sustainability, Machine learning, CIS, Data wrangling, Public sector, APN, Cloud computing, NTT, Ecosystem, DARPA, Mobile phone

NTT Research, Inc. , a division of NTT (TYO:9432), today announced plans to hold Upgrade 2024 , NTT’s Global Research & Innovation Summit, on April 10-11, 2024.

Key Points: 
  • NTT Research, Inc. , a division of NTT (TYO:9432), today announced plans to hold Upgrade 2024 , NTT’s Global Research & Innovation Summit, on April 10-11, 2024.
  • Day 2 (April 11) of Upgrade 2024 will kick-off at the Metreon with remarks by NTT Research President Gomi.
  • The second, on basic research, features NTT Venture Capital (VC) Founding Partner Vab Goel, NTT Senior Executive Vice President CTO Katsuhiko Kawazoe and NTT Research President Gomi.
  • NTT Research invites business leaders, students, academics, researchers and journalists to attend, as well as NTT customers, employees, partners and stakeholders.

Drug insurance: A single-payer pharmacare program would jeopardize coverage quality for 21 million Canadians

Retrieved on: 
木曜日, 2月 22, 2024
Public policy, Health Canada, Entrepreneurship, Liberal Party, Federation, Risk, Suggestion, Publication, MEI, Insurance, Health insurance

“All across the country, private drug insurance plans cover more treatments than governmental plans,” explains Emmanuelle B. Faubert, economist at the MEI and author of the study.

Key Points: 
  • “All across the country, private drug insurance plans cover more treatments than governmental plans,” explains Emmanuelle B. Faubert, economist at the MEI and author of the study.
  • Nearly 25 million Canadians have private drug insurance coverage.
  • Between 2018 and 2021, private drug insurance plans covered 51 per cent more drugs on average than public plans.
  • The MEI study indicates that even if a public plan as generous as Quebec’s were extended across the country, 21.5 million Canadians would risk seeing the quality of their insurance coverage fall.

MEI Pharma Reports Second Quarter Fiscal Year 2024 Results and Operational Highlights

Retrieved on: 
火曜日, 2月 13, 2024
Science, Biotechnology, Research, Pharmaceutical, Oncology, General Health, Health, Clinical Trials, Cohort, Oxidative phosphorylation, Hematology, Investment, Calendar, Exposition, Bevacizumab, Safety, Society, Lymphoid leukemia, OXPHOS, Patient, Acute myeloid leukemia, CDK9, MEI, Colorectal cancer, Wind, Pharmaceutical industry

As of December 31, 2023, MEI had $59.5 million in cash, cash equivalents, and short-term investments with no outstanding debt.

Key Points: 
  • As of December 31, 2023, MEI had $59.5 million in cash, cash equivalents, and short-term investments with no outstanding debt.
  • Research and development expenses decreased by $11.4 million to $3.9 million for the quarter ended December 31, 2023, compared to $15.3 million for the quarter ended December 31, 2022.
  • General and administrative expenses decreased by $0.5 million to $8.0 million for the quarter ended December 31, 2023, compared to $8.5 million for the quarter ended December 31, 2022.
  • MEI recognized no revenue for the quarter ended December 31, 2023, compared to $32.7 million for the quarter ended December 31, 2022.

Moutai Paints the Boundless “MEI” of 2024 with the World!

Retrieved on: 
土曜日, 2月 3, 2024
Cream, ESG, Life, Taste, Environment, Philosophy, MEI, Soil, Marketing, Social media, Water, Chinese New Year, Culture, Rejuvenation, Conference

At the beginning of 2024, Moutai has begun a new journey of pursuing the “boundless MEI”.

Key Points: 
  • At the beginning of 2024, Moutai has begun a new journey of pursuing the “boundless MEI”.
  • In 2023, Moutai ranked third in Kantar BrandZ’s Most Valuable Chinese Brands and won the 20th “China Quality Award”.
  • With “The Global Expedition with Moutai MEI”, Moutai has developed a new pattern of internationalization.
  • Moutai’s cultural connotations have been spread through “MEI Moutai, MEI World” brand cultural activities.